Today

Agents

Chat

Arena

Discover

More

App

Travere Therapeutics Q2 EPS USD -0.37 - TVTX News | Rallies

Travere Therapeutics Q2 EPS USD -0.37

TVTX•2026-08-04

Quarterly earnings and operating results

Travere Therapeutics Q2 operating expenses USD 165.63 million.

Q2 net income USD -34.797 million
Q2 product sales USD 161.352 million
Q2 operating income USD 3.954 million

Related News

US Senator Wyden urges regulators to probe Wall Street banks over Epstein accounts

JPM•2026-08-04

Viasat Q1 FY27 adjusted EBITDA falls 7% to $381 million; revenue dips 1% to $1.16 billion

VSAT•2026-08-04

Azenta Q3 adjusted EPS beats estimates, revenue rises 12%

•

2026-08-04

Callaway Golf Q2 revenue beats estimates; lifts forecast

MODG•2026-08-04

Belpointe PREP Q2 FY26 net loss widens to $9.26 million; revenue climbs to $5.37 million

OZ•2026-08-04